Cache Advisors LLC purchased a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 14,096 shares of the company's stock, valued at approximately $753,000.
A number of other institutional investors have also recently made changes to their positions in the company. Tidal Investments LLC purchased a new position in shares of Doximity during the 4th quarter valued at $246,000. Teza Capital Management LLC purchased a new position in shares of Doximity during the 4th quarter valued at $2,034,000. Strategic Global Advisors LLC purchased a new position in shares of Doximity during the 4th quarter valued at $1,506,000. Snowden Capital Advisors LLC purchased a new position in shares of Doximity during the 4th quarter valued at $248,000. Finally, Raiffeisen Bank International AG purchased a new position in shares of Doximity during the 4th quarter valued at $179,000. Hedge funds and other institutional investors own 87.19% of the company's stock.
Doximity Price Performance
Doximity stock traded up $0.41 during trading hours on Thursday, reaching $52.05. The company had a trading volume of 809,665 shares, compared to its average volume of 2,090,753. The company has a 50-day moving average price of $55.68 and a 200 day moving average price of $58.15. The firm has a market cap of $9.72 billion, a price-to-earnings ratio of 52.06, a P/E/G ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 12-month low of $25.00 and a 12-month high of $85.21.
Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, May 15th. The company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. The firm's revenue was up 17.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.25 EPS. As a group, research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current year.
Insiders Place Their Bets
In other news, CFO Anna Bryson sold 45,000 shares of Doximity stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer now directly owns 357,165 shares in the company, valued at approximately $20,440,552.95. This trade represents a 11.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total value of $113,860.00. Following the completion of the sale, the director now owns 16,618 shares in the company, valued at approximately $946,062.74. This represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 37.40% of the company's stock.
Analyst Ratings Changes
A number of analysts recently issued reports on DOCS shares. Needham & Company LLC decreased their price objective on Doximity from $82.00 to $67.00 and set a "buy" rating on the stock in a research note on Friday, May 16th. The Goldman Sachs Group set a $50.00 target price on Doximity and gave the stock a "neutral" rating in a research note on Wednesday, May 21st. Leerink Partners upgraded Doximity from a "market perform" rating to an "outperform" rating and upped their target price for the stock from $60.00 to $90.00 in a research note on Friday, February 7th. Leerink Partnrs upgraded Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Finally, Morgan Stanley decreased their target price on Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 24th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $61.89.
Check Out Our Latest Analysis on Doximity
About Doximity
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories
Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
